Creating yellow seed Camelina sativa with enhanced oil accumulation by CRISPR ‐mediated disruption of Transparent Testa 8
Plant Biotechnology Journal · 2024-10 · 22 (10) · 2773-2784
DOI: 10.1111/pbi.14403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plant Biotechnology Journal, online erschienen am 10.06.2024. Verfasst von Yuanheng Cai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Brookhaven National Laboratory, Upton, NY, USA. Hauptthemen laut MEDLINE: Seeds, CRISPR-Cas Systems, Brassicaceae, Plant Oils. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Basic Energy Sciences, Biological and Environmental Research.
Abstract (Originalsprache)
Camelina ( Camelina sativa L.), a hexaploid member of the Brassicaceae family, is an emerging oilseed crop being developed to meet the increasing demand for plant oils as biofuel feedstocks. In other Brassicas, high oil content can be associated with a yellow seed phenotype, which is unknown for camelina. We sought to create yellow seed camelina using CRISPR/Cas9 technology to disrupt its Transparent Testa 8 (TT8) transcription factor genes and to evaluate the resulting seed phenotype. We identified three TT8 genes, one in each of the three camelina subgenomes, and obtained independent CsTT8 lines containing frameshift edits. Disruption of TT8 caused seed coat colour to change from brown to yellow reflecting their reduced flavonoid accumulation of up to 44%, and the loss of a well‐organized seed coat mucilage layer. Transcriptomic analysis of CsTT8 ‐edited seeds revealed significantly increased expression of the lipid‐related transcription factors LEC1 , LEC2 , FUS3 , and WRI1 and their downstream fatty acid synthesis‐related targets. These changes caused metabolic remodelling with increased fatty acid synthesis rates and corresponding increases in total fatty acid (TFA) accumulation from 32.4% to as high as 38.0% of seed weight, and TAG yield by more than 21% without significant changes in starch or protein levels compared to parental line. These data highlight the effectiveness of CRISPR in creating novel enhanced‐oil germplasm in camelina. The resulting lines may directly contribute to future net‐zero carbon energy production or be combined with other traits to produce desired lipid‐derived bioproducts at high yields.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Brookhaven National Laboratory, Upton, NY, USA.
- Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY, USA.
- Department of Plant Sciences and Plant Pathology, Montana State University, Bozeman, MT, USA.
ORCID-Profile: Yuanheng Cai, Yuanxue Liang, Hai Shi, Jodie Cui, Shreyas Prakash, Jianhui Zhang, Sanket Anaokar, Jin Chai, Jorg Schwender, Chaofu Lu, Xiao-Hong Yu, John Shanklin
Förderung
- Basic Energy Sciences
- Biological and Environmental Research
Zitieren
APA
Cai, Y., Liang, Y., Shi, H., Cui, J., Prakash, S., Zhang, J., Anaokar, S., Chai, J., Schwender, J., Lu, C., Yu, X. H., & Shanklin, J. (2024). Creating yellow seed Camelina sativa with enhanced oil accumulation by CRISPR ‐mediated disruption of Transparent Testa 8. Plant Biotechnology Journal, 22(10), 2773-2784. https://doi.org/10.1111/pbi.14403
Vancouver
Cai Y, Liang Y, Shi H, Cui J, Prakash S, Zhang J, et al. Creating yellow seed Camelina sativa with enhanced oil accumulation by CRISPR ‐mediated disruption of Transparent Testa 8. Plant Biotechnology Journal. 2024;22(10):2773-2784. doi:10.1111/pbi.14403
BibTeX
@article{Cai2024,
author = {Cai, Yuanheng and Liang, Yuanxue and Shi, Hai and Cui, Jodie and Prakash, Shreyas and Zhang, Jianhui and Anaokar, Sanket and Chai, Jin and Schwender, Jorg and Lu, Chaofu and Yu, Xiao-Hong and Shanklin, John},
title = {Creating yellow seed Camelina sativa with enhanced oil accumulation by CRISPR ‐mediated disruption of Transparent Testa 8},
journal = {Plant Biotechnology Journal},
year = {2024},
volume = {22},
number = {10},
pages = {2773--2784},
doi = {10.1111/pbi.14403}
}
EUVIMED